Skip to main content
. Author manuscript; available in PMC: 2019 Feb 12.
Published in final edited form as: J Immunol Sci. 2018 Jul 28;Suppl:113–121.

Table 2. MCV1 and MCV2 coverage and drop out rates. WHO-UNICEF coverage estimates. 2015.

Country MCV1 MCV2 MCV1 - MCV2 drop-out rate1 Type of vaccine used as of Dec 2016 Age of MCV2 administration in months # of years since country started reporting MCV2 coverage
Algeria 95% 99% -4.2% M 6 years 16
Angola 55% 26% 52.7% M 15 months 1
Botswana 97% 85% 12.4% MR 18 months 3
Burkina Faso 88% 50% 43.2% MR 15 months 2
Burundi 93% 65% 30.1% M 18 months 3
Cabo Verde 92% 95% -3.3% MMR 15 months 5
Eritrea 85% 75% 11.8% M 18 months 1
Gambia 97% 77% 20.6% M 18 months 4
Ghana 89% 63% 29.2% MR 18 months 4
Kenya 75% 28% 62.7% MR 18 months 1
Lesotho 90% 82% 8.9% M 18 months 15
Malawi 87% 8% 90.8% M 15 months 1
Mauritius 99% 85% 14.1% MMR 5 years 12
Niger 73% 16% 78.1% M 16 months 2
Rwanda 97% 87% 10.3% MR 15 months 1
Sao Tome and Principe 93% 76% 18.3% MR 18 months 2
Senegal 80% 54% 32.5% MR 15 months 2
Seychelles 98% 98% 0.0% MMR 6 years 15
Sierra Leone 76% 60% 21.1% M 15 months 1
South Africa 76% 63% 17.1% M 12 months 16
Swaziland 78% 89% -14.1% MR 15 months 14
Tanzania 99% 57% 42.4% MR 18 months 2
Zambia 90% 47% 47.8% M 18 months 2
1

MCV1 – MCV2 drop-out rate = (MCV1 – MCV2)/ MCV1 coverage